CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02171 CARSGEN-B

Closed 07-17 16:08:11

15.980

-1.100

-6.44%

High17.080	Low14.700	Vol6.44M
Open17.080	D1 Closing17.080	Amplitude13.93%
Mkt Cap9.49B	Tradable Cap9.49B	Total Shares594.00M
T/O99.11M	T/O Rate1.08%	Tradable Shares594.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"CARSGEN-B","latestPrice":15.98,"timestamp":1784275691004,"preClose":17.08,"halted":0,"volume":6438500,"delay":0,"changeRate":-0.06440281030444953,"floatShares":594000000,"shares":594000000,"eps":-0.177264,"marketStatus":"Closed","change":-1.1,"latestTime":"07-17 16:08:11","open":17.08,"high":17.08,"low":14.7,"amount":99105830,"amplitude":0.139344,"askPrice":15.99,"askSize":5000,"bidPrice":15.98,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":-0.182,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":17.08,"openAndCloseTimeList":[[1784251800000,1784260800000],[1784264400000,1784275200000]],"volumeRatio":1.778849,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171/tweets","defaultTab":"tweets","newsList":[{"id":"1156845057","title":"Movement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1156845057","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156845057?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:04","pubTimestamp":1784253884,"startTime":"0","endTime":"0","summary":"On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189418681","title":"CARSGEN-B Shares Surge Over 7% in Session as CT041 Passes Initial Review for 2026 Commercial Health Insurance Innovation Drug Catalog","url":"https://stock-news.laohu8.com/highlight/detail?id=1189418681","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189418681?lang=en_us&edition=fundamental","pubTime":"2026-07-16 11:50","pubTimestamp":1784173827,"startTime":"0","endTime":"0","summary":"Shares of CARSGEN-B (HKEX: 02171) rose more than 7% during the trading session. At the time of writing, the stock is up 5.32% to HK$16.83, with a trading turnover of HK$52.48 million. On July 16th,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1585","IBBQ","02171","06978","MEDX","BK1574","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143100649","title":"Movement Alert｜CARsgen Therapeutics-B Rises 5.51% in Regular Trading, Kelimei Post-Surgical Consolidation Therapy Positive Results Accepted for ESMO Poster Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1143100649","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143100649?lang=en_us&edition=fundamental","pubTime":"2026-07-16 10:28","pubTimestamp":1784168890,"startTime":"0","endTime":"0","summary":"On July 16, CARsgen Therapeutics-B rose 5.51% in regular trading, trading at HK$16.89/share, with turnover of HK$29.95 million.On the news front, the company announced on July 15 that preliminary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166244460","title":"Hong Kong Stocks Midday Update: Hang Seng Index Rises 1.46%, Innovation Pharma Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=1166244460","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166244460?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:12","pubTimestamp":1784088731,"startTime":"0","endTime":"0","summary":"The Hong Kong market saw gains at midday, with the Hang Seng Index advancing 1.46%, adding 354 points to reach 24,695. The Hang Seng Tech Index also climbed, rising 1.39%. Trading volume for the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07200","HSIBNI","HSImain","07300","03033","BK1585","03067","03423","02833","03088","07226","03037","03032","HSI","03417","BK1587","83115","02837","HHImain","07500","HTImain","03419","02171","BK1161","MCHmain","HSTECH","09067","BK1574","513600","82800","02800","09088","09115","03115","07552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124494472","title":"Shares of CARSGEN-B Surge Over 6% Ahead of Key Study Presentation at 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1124494472","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124494472?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:56","pubTimestamp":1784084188,"startTime":"0","endTime":"0","summary":"Shares of CARSGEN-B (ASX: 02171) have surged more than 6%. At the time of writing, the stock is up 5.94% to HK$16.42, with a turnover of HK$32.63 million.On July 15, the company announced that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","VXUS","BK4588","02171","KCAI","BK1574","BK1585","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140460813","title":"Movement Alert｜CARsgen Therapeutics Rises 5.23% in Regular Trading, Satri-Cel Post-Surgical Consolidation Trial Results Accepted for ESMO Poster Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1140460813","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140460813?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:43","pubTimestamp":1784083384,"startTime":"0","endTime":"0","summary":"On July 15, CARsgen Therapeutics-B (02171.HK) rose 5.23% in regular trading, trading at HK$16.28, with turnover of HK$29.57 million.On the news front, the company announced that preliminary positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174501419","title":"CARsgen’s Satri-cel Shows No Post-operative Recurrence in IIT; Data Accepted for Presentation at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1174501419","media":"Bulletin Express","labels":["conferences","dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174501419?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:21","pubTimestamp":1784074868,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited (CARsgen) reported that preliminary data from its investigator-initiated trial (IIT) CT041-CG4010 of satricabtagene autoleucel (satri-cel, CT041) in China have...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651519487","title":"Carsgen Says Satri-cel Gastric Cancer Consolidation Trial Shows no Recurrences to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2651519487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651519487?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:00","pubTimestamp":1784073639,"startTime":"0","endTime":"0","summary":"CARsgen says satri-cel gastric cancer consolidation trial shows no recurrences to dateCARsgen disclosed preliminary positive results for satri-cel as consolidation therapy in resected gastric or gastr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL43v4VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1585","BK1574","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649935853","title":"Carsgen Files HKEX Next-day Disclosure Return Reporting Share Repurchase and Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2649935853","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649935853?lang=en_us&edition=fundamental","pubTime":"2026-07-07 22:11","pubTimestamp":1783433489,"startTime":"0","endTime":"0","summary":"CARsgen files HKEX next-day disclosure return reporting share repurchase and cancellationCARsgen filed a next-day disclosure return showing 725,000 shares repurchased for cancellation.270,000 shares w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL5ff7N7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1587","BK1574","BK1585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156195176","title":"CARsgen Keeps Share Structure Steady in June 2026; 17.68 Million Options Remain Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1156195176","media":"Bulletin Express","labels":["shareholding","SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156195176?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:03","pubTimestamp":1783425834,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited reported no changes to its share capital for June 2026, maintaining stable equity metrics across authorised, issued and treasury shares. Authorised and Issued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176659568","title":"Movement Alert｜CARsgen Therapeutics-B Falls 5.13% in Regular Trading, Strategic Pivot Away from Autologous CAR-T Pipeline Sparks Market Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1176659568","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176659568?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:03","pubTimestamp":1783393421,"startTime":"0","endTime":"0","summary":"On July 7, CARsgen Therapeutics-B declined 5.13% in regular trading, trading at HKD 15.19/share, with turnover of HKD 17.54 million.On the news front, company founder and CEO Li Zonghai recently...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648966009","title":"CARsgen Therapeutics (SEHK:2171) Is Up 20.8% After First Solid Tumor CAR T Approval - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2648966009","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648966009?lang=en_us&edition=fundamental","pubTime":"2026-07-04 01:44","pubTimestamp":1783100687,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings announced that China’s National Medical Products Administration has approved satricabtagene autoleucel (satri-cel), an autologous Claudin18.2-targeted CAR T-cell therapy, for Claudin18.2-positive, HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma in patients who have failed at least two prior treatments.\nAs the first CAR T-cell therapy approved globally for solid tumors, satri-cel could reshape treatment options in high-burden cancers like...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-is-up-208-after-first-solid-tu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-is-up-208-after-first-solid-tu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CHAT","ARTY","LENZ","BK4139","AIPO","VTHR","BK1587","BK4007","BK4022","QTOC","BK1574","02171","BK1161","CAR","BK1585","AGIX","BK4539","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164001411","title":"Movement Alert｜CARsgen Therapeutics-B Rises 5.14% in Regular Trading, Buyback Plan and Biotech Sector Strength Fuel Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1164001411","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164001411?lang=en_us&edition=fundamental","pubTime":"2026-07-03 13:13","pubTimestamp":1783055627,"startTime":"0","endTime":"0","summary":"On July 3, CARsgen Therapeutics-B rose 5.14% in regular trading, trading at HKD 15.85/share, with turnover of HKD 45.27 million.The rally was driven by the ongoing support from the company's share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191082168","title":"Movement Alert｜CARsgen Therapeutics-B Rises 5.19% in Regular Trading, Buyback Plan and Sector Rally Continue to Support Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1191082168","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191082168?lang=en_us&edition=fundamental","pubTime":"2026-07-02 15:12","pubTimestamp":1782976332,"startTime":"0","endTime":"0","summary":"On July 2, CARsgen Therapeutics-B rose 5.19% in regular trading, trading at HK$15.01/share, with turnover of HK$69.48 million. The stock continued its recovery trajectory following a sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647883545","title":"Following Satri Cel Approval Is CARsgen Therapeutics Holdings (SEHK:2171) Fully Priced?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647883545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647883545?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:15","pubTimestamp":1782764115,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh investor attention after China’s National Medical Products Administration approved satricabtagene autoleucel, the first CAR T-cell therapy cleared globally for a solid tumor indication.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe satri-cel approval came after a mixed period for CARsgen Therapeutics Holdings. The 1-day share price return was 7.68%, while the 30-day share price return was down 21.81% and the 1-year...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/following-satri-cel-approval-is-carsgen-therapeutics-holding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/following-satri-cel-approval-is-carsgen-therapeutics-holding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK4007","BK1587","02171","BK4539","BK1585","BK4139","LENZ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136658346","title":"Movement Alert｜CARsgen Therapeutics-B Rises 6.31% in Regular Trading, Buyback Plan and Sector Recovery Fuel Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1136658346","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136658346?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:15","pubTimestamp":1782699339,"startTime":"0","endTime":"0","summary":"On June 29, CARsgen Therapeutics-B rose 6.31% in regular trading, trading at HK$13.85/share, with turnover of approximately HK$35.5 million. The rebound was supported by the company's recently...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154161276","title":"CARSGEN-B Shares Surge in Afternoon Trading Following Share Buyback Plan Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1154161276","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154161276?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:40","pubTimestamp":1782452423,"startTime":"0","endTime":"0","summary":"Shares of CARSGEN-B (02171) experienced a notable rise during the afternoon session, gaining over 3%. At the time of writing, the stock was up 2.9%, trading at HK$12.78 with a turnover of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1161","BK4588","BK1585","VXUS","02171","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646333982","title":"Carsgen Therapeutics Climbs on Board Nod for Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2646333982","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646333982?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:39","pubTimestamp":1782452353,"startTime":"0","endTime":"0","summary":"BUZZ-CARsgen Therapeutics climbs on board nod for share buyback** Shares of CARsgen Therapeutics Holdings2171.HKclimb 3.9% to HK$12.9, on track to snap three straight sessions of declines** Chinese ce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL1N42Y05A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1574","BK1585","02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193427011","title":"CARSGEN-B Announces Share Buyback Plan of Up to 5% of Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1193427011","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193427011?lang=en_us&edition=fundamental","pubTime":"2026-06-26 12:42","pubTimestamp":1782448953,"startTime":"0","endTime":"0","summary":"The board of CARSGEN-B (02171) has given the green light to a new share repurchase initiative, as per a recent company announcement.This move follows the granting of a share buyback mandate by...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02171","BK1585","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646048335","title":"Carsgen Therapeutics Holdings - Approves Share Repurchase Plan for up to 30.12 Mln Shares, About 5% of Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646048335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646048335?lang=en_us&edition=fundamental","pubTime":"2026-06-26 12:27","pubTimestamp":1782448035,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42X0TO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02171","BK1585","BK1161","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.1731},{"period":"1month","weight":0.079},{"period":"3month","weight":-0.3141},{"period":"6month","weight":0.055},{"period":"1year","weight":-0.2375},{"period":"ytd","weight":0.1502}],"compareEarnings":[{"period":"1week","weight":0.0407},{"period":"1month","weight":0.021},{"period":"3month","weight":-0.044},{"period":"6month","weight":-0.0684},{"period":"1year","weight":0.02},{"period":"ytd","weight":-0.0243}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07858},{"month":2,"riseRate":0.6,"avgChangeRate":0.230493},{"month":3,"riseRate":0.2,"avgChangeRate":-0.058535},{"month":4,"riseRate":0.4,"avgChangeRate":-0.02351},{"month":5,"riseRate":0.6,"avgChangeRate":0.035849},{"month":6,"riseRate":0.4,"avgChangeRate":-0.015777},{"month":7,"riseRate":0.5,"avgChangeRate":0.020179},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"CARSGEN-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARSGEN-B,02171,CARSGEN-B股票,CARSGEN-B股票老虎,CARSGEN-B股票老虎国际,CARSGEN-B行情,CARSGEN-B股票行情,CARSGEN-B股价,CARSGEN-B股市,CARSGEN-B股票价格,CARSGEN-B股票交易,CARSGEN-B股票购买,CARSGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}